1887

Microbiology Society logo

Volume 88, Issue 2

Cross-resistance Relationships among the Aminoglucoside Antibiotics in Free

Abstract

SUMMARY: Phenotypes of isolates of H37RV showing resistance to the aminoglucoside antibiotics streptomycin, viomycin, kanamycin, capreomycin, tuberactinomycin N, lividomycin and paromomycin could be grouped into the following types: (1) resistant only to different levels of streptomycin; (2) resistant only to a low level of kanamycin; (3) triply resistant, to low levels of viomycin, tuberactinomycin N and capreomycin; (4) triply resistant, to a low level of kanamycin and high levels of lividomycin and paromomycin; (5) quadruply resistant, to a low level of capreomycin and high levels of kanamycin, lividomycin and paromomycin; (6) hextuply resistant, to high levels of viomycin, tuberactinomycin N, capreomycin, kanamycin, lividomycin, and paromomycin. Three modified types of the latter were also observed. Appearance rates of the six types were estimated as 10 to 10, 10, 10 to 10, 10, 10, and 10 to 10, respectively, in a total viable population of the parent strain. Mutations to all phenotypes were considered to be produced by single mutations. According to cross-resistance relationships, aminoglucoside antibiotics were classified into three groups: (I) streptomycin; (II) viomycin, tuberactinomycin N and capreomycin; (III) kanamycin, lividomycin and paromomycin. No cross-resistance relationship between streptomycin and other antibiotics was observed. Resistances to viomycin, tuberactinomycin N and capreomycin occurred by single mutation to type 3. Resistances to kanamycin, lividomycin and paromomycin occurred by single mutations to types 4 and 5. Low resistance to capreomycin was produced by mutation to type 5. Therefore capreomycin was considered to be an intermediate between the second and third groups. These two groups had a close relationship, as resistance to all six agents in these groups could be produced by a single mutation to type 6 (and its modified types).

  • Received:
  • Revised:
  • Published Online:
© Society for General Microbiology 1975
Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-88-2-269
1975-06-01
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/micro/88/2/mic-88-2-269.html?itemId=/content/journal/micro/10.1099/00221287-88-2-269&mimeType=html&fmt=ahah

References

  1. Canetti G., Armstrong A. R., Bartmann K., Cetrangolo A., Hobby G. L., Lucchesi M., Stewart S. M., Sula L., Tsukamura M., Schmiedel A. 1966; Recent progress in drug resistance tests for tubercle bacilli (major and minor drugs). Bulletin of the International Union against Tuberculosis 37:185–225
     [Google Scholar]
  2. Koseki Y., Okamoto S. 1963; Studies on cross-resistance between capreomycin and certain other anti-mycobacterial agents. Japanese Journal of Medical Science and Biology 16:31–38
     [Google Scholar]
  3. Koseki Y., Okamoto S., Murohashi T. 1973; Antituberculous activities of the tuberactinomycins in vitro and in experimental animals. Kekkaku 48:189–196
     [Google Scholar]
  4. Saito T. 1972; Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. Japanese Journal of Tuberculosis and Chest Diseases 18:7–19
     [Google Scholar]
  5. Steenken W., Montalbine V., Thurston J. R. 1959; The antituberculous activity of kanamycin in vitro and in the experimental animal (guinea pig). American Review of Tuberculosis 79:66–71
     [Google Scholar]
  6. Torii F., Yamamoto M., Hayashi M., Noda Y., Tsukamura M. 1959; Studies on the kanamycin-resistance of Mycobacterium tuberculosis. II. Kanamycin-sensitivity of various drug-resistant strains. Journal of Antibiotics A 12:103–104
     [Google Scholar]
  7. Toyohara H., Nagata A., Hayano K., Abe J. 1969; Study on the antituberculous activity of tuberactinomycin, a new antimicrobial drug. American Review of Respiratory Disease 100:228–230
     [Google Scholar]
  8. Tsukamura M. 1958; Drug resistance test for kanamycin resistance of tubercle bacilli. Medicine and Biology (Tokyo) 49:87–90
     [Google Scholar]
  9. Tsukamura M. 1959; Further studies on the one-way cross-resistance in Mycobacterium tuberculosis with special reference to streptomycin resistance, kanamycin resistance, and viomycin resistance. Japanese Journal of Genetics 34:275–281
     [Google Scholar]
  10. Tsukamura M. 1961; Biological and biochemical studies on the streptomycin-dependent mutants of a Mycobacterium (Jucho). I. Morphological characteristics and relationship between streptomycin dependence and kanamycin resistance. Iryo 15:30–35
     [Google Scholar]
  11. Tsukamura M. 1964; ‘Actual count’ method for the resistance test of tubercle bacilli. Japanese Journal of Tuberculosis 12:46–54
     [Google Scholar]
  12. Tsukamura M. 1969; Cross-resistance relationships between capreomycin, kanamycin and viomycin resistances in tubercle bacilli from patients. American Review of Respiratory Disease 99:780–782
     [Google Scholar]
  13. Tsukamura M. 1972; Cross-resistance relationships between paromomycin (aminosidine), lividomycin, kanamycin, and capreomycin resistances of Mycobacterium tuberculosis. Chemotherapy (Tokyo) 20:687–694
     [Google Scholar]
  14. Tsukamura M. 1974; Resistance pattern to tuberactinomycin-N and cross resistance relationships between tuberactinomycin-N, lividomycin, capreomycin, viomycin, kanamycin and streptomycin resistances of Mycobacterium tuberculosis(H37RV). Chemotherapy (Tokyo) 22:1115–1121
     [Google Scholar]
  15. Tsukamura M., Mizuno S., Yamamoto M. 1970; Antituberculous action of a new antibiotic, lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents. Kekkaku 45:263–272
     [Google Scholar]
  16. Tsukamura M., Noda Y., Yamamoto M. 1959a; Studies on the kanamycin resistance in Mycobacterium tuberculosis. V. Sensitivity of kanamycin-resistant mutants to various antituberculous drugs and mutation frequency to various drug resistance in kanamycin-resistant mutants. Journal of Antibiotics A 12:323–327
     [Google Scholar]
  17. Tsukamura M., Noda Y., Yamamoto M., Hayashi M., Torii F. 1959b; Cross-resistance problem of Mycobacterium tuberculosis with special reference to kanamycin resistance. Medicine and Biology (Tokyo) 50:4–9
     [Google Scholar]
  18. Tsukamura M., Toyama H., Mizuno S., Tsukamura S. 1967; Cross resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistances of Myocbacterium tuberculosis. Kekkaku 42:399–404
     [Google Scholar]
  19. Tsukamura M., Toyama H., Tsukamura S. 1963; Resistance pattern of Mycobacterium tuberculosis to cycloserine. Japanese Journal of Tuberculosis 11:36–43
     [Google Scholar]
  20. Tsukamura S., Tsukamura M. 1963; Comparison of the degree of drug resistance between ‘1% Ogawa medium’ and ‘Lowenstein-Jensen medium’. Japanese Journal of Tuberculosis 11:44–47
     [Google Scholar]
  21. Verbist L., Gyselen A. 1964; Capreomycin susceptibility of strains resistant to streptomycin and/or viomycin. American Review of Respiratory Disease 90:640–641
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-88-2-269
Loading
Cross-resistance Relationships among the Aminoglucoside Antibiotics in Mycobacterium tuberculosis
Microbiology 88, 269 (1975); https://doi.org/10.1099/00221287-88-2-269
/content/journal/micro/10.1099/00221287-88-2-269
/content/journal/micro/10.1099/00221287-88-2-269
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error